findmyKOL
Clinical trialNCT03029585TerminatedPhase 2Interventional

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

SponsorNanOlogy, LLCEnrollment10Ovarian Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Chicago

    Chicago, Illinois, United States

  • Greater Baltimore Medical Center

    Baltimore, Maryland, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Suny Downstate

    Brooklyn, New York, United States

  • Magee-Womens Hospital of Upmc

    Pittsburgh, Pennsylvania, United States

  • Women & Infants Hospital of Rhode Island

    Providence, Rhode Island, United States

  • University of Texas Southwestern

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Apr 2017
Primary completion
4 Nov 2019
Completion
4 Nov 2019
Last update posted
27 Apr 2021
Registered enrollment
10
Registry id
NCT03029585

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.